Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for Diagnosis of Small Renal Masses
NCT01062178Phase 2Completed
- Sponsor
- University Health Network
- Start
- Oct 2009
- Primary completion
- Oct 2012
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perflutren lipid microspheres, sponsored by University Health Network. Primary endpoint: Correlation of CEUS features with final pathology at 18 months. Started Oct 2009; status: completed.
02
Drugs
perflutren lipid microspheres
Beyond the preview
Go deeper on NCT01062178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01062178.